Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

558.87
+13.412.46%
Volume:1.66M
Turnover:920.76M
Market Cap:60.34B
PE:14.09
High:583.28
Open:583.01
Low:542.89
Close:545.46
Loading ...

Wolfe Research Adjusts Price Target on Regeneron Pharmaceuticals to $800 From $925

MT Newswires Live
·
04 Jun

RBC Capital Reaffirms Their Hold Rating on Regeneron (REGN)

TIPRANKS
·
03 Jun

Bernstein Sticks to Its Buy Rating for Regeneron (REGN)

TIPRANKS
·
03 Jun

Regeneron Pharma Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
02 Jun

BUZZ-Kymera rises after positive early-stage results for experimental drug

Reuters
·
02 Jun

BRIEF-Regeneron Expands Clinical-Stage Obesity Portfolio

Reuters
·
02 Jun

Kymera Stock Jumps. New Dermatitis Pill Could Challenge Regeneron Blockbuster. -- Barrons.com

Dow Jones
·
02 Jun

Hansoh Pharmaceutical Signs $80 Million License Agreement with Regeneron for Drug Development

Reuters
·
02 Jun

Regeneron Says Libtayo Shows Strong Results in Adjuvant Skin Cancer Trial

MT Newswires Live
·
02 Jun

Truist Financial Reaffirms Their Buy Rating on Regeneron (REGN)

TIPRANKS
·
02 Jun

Regeneron Secures Global Rights to Novel GLP-1/GIP Receptor Agonist, Expanding Obesity Treatment Portfolio with Strategic In-Licensing from Hansoh Pharmaceuticals

Reuters
·
02 Jun

Regeneron Pharmaceuticals Unveils Promising Phase 2 COURAGE Trial Results, Highlighting Enhanced Weight Loss with Muscle Preservation

Reuters
·
02 Jun

RPT-BUZZ-US stocks weekly: Topsy-turvy

Reuters
·
02 Jun

Bernstein Adjusts PT on Regeneron Pharmaceuticals to $750 From $896, Maintains Outperform Rating

MT Newswires Live
·
02 Jun

U.S. RESEARCH ROUNDUP- Charter Communications, Ford, General Motors

Reuters
·
02 Jun

Regeneron announces analyses from Phase 3 C-Post trial

TIPRANKS
·
02 Jun

BRIEF-Regeneron Pharmaceuticals Inc Says Libtayo Shows 68% Reduction In Risk Of Disease Recurrence Or Death

Reuters
·
31 May

Regeneron Pharmaceuticals Submits Regulatory Applications for Libtayo in Adjuvant Treatment of High-Risk CSCC in US and EU

Reuters
·
31 May

Post-Bell | S&P 500 Posts Biggest Monthly Pct Gain Since November 2023; Nvidia and Tesla Drop 3%; Gap Sinks 20%

Tiger Newspress
·
31 May

Regeneron price target lowered to $645 from $686 at Leerink

TIPRANKS
·
31 May